The tale of two organs: allogeneic hematopoietic stem cell transplantation following liver transplantation in a myelofibrosis patient.
作者信息
Bastin Donald J, Mount Gillian, Hsia Cyrus C, Jarrar Mohammad, McCann Kit, Xenocostas Anargyros, Teriaky Anouar, Deotare Uday
机构信息
Western University, London, ON, Canada.
Windsor Regional Hospital, Windsor, ON, Canada.
出版信息
Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):502-504. doi: 10.1016/j.htct.2021.11.011. Epub 2021 Dec 17.
Abstract
摘要
相似文献
1
The tale of two organs: allogeneic hematopoietic stem cell transplantation following liver transplantation in a myelofibrosis patient.两个器官的故事：一名骨髓纤维化患者肝移植后接受异基因造血干细胞移植
Hematol Transfus Cell Ther. 2023 Oct-Dec;45(4):502-504. doi: 10.1016/j.htct.2021.11.011. Epub 2021 Dec 17.
2
Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center.异基因造血干细胞移植治疗原发性骨髓纤维化：单中心 20 年经验。
Balkan Med J. 2023 May 8;40(3):197-204. doi: 10.4274/balkanmedj.galenos.2023.2022-2-32. Epub 2023 Mar 24.
3
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.异基因造血干细胞移植治疗原发性血小板增多症和真性红细胞增多症后骨髓纤维化。
Intern Med. 2020;59(16):1947-1956. doi: 10.2169/internalmedicine.4375-19. Epub 2020 Aug 15.
4
[Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report].[原发性骨髓纤维化患者重复单倍体相合异基因造血干细胞移植并TCRαβ/CD19去除。病例报告]
Ter Arkh. 2021 Jul 23;93(7):805-810. doi: 10.26442/00403660.2021.07.200948.
5
Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.动态国际预后评分系统评分、移植前治疗和慢性移植物抗宿主病决定了异基因造血干细胞移植治疗骨髓纤维化的预后。
Haematologica. 2012 Oct;97(10):1574-81. doi: 10.3324/haematol.2011.061168. Epub 2012 Apr 4.
6
[Allogeneic hematopoietic stem cell transplantation for myeloproliferative neoplasms].异基因造血干细胞移植治疗骨髓增殖性肿瘤
Rinsho Ketsueki. 2019;60(9):1148-1156. doi: 10.11406/rinketsu.60.1148.
7
Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后骨髓纤维化相关肺动脉高压的缓解
Pulm Circ. 2016 Dec;6(4):611-613. doi: 10.1086/687291.
8
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.异基因造血干细胞移植治疗骨髓纤维化
Curr Opin Hematol. 2006 Mar;13(2):74-8. doi: 10.1097/01.moh.0000203191.99447.98.
9
Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.脾照射作为骨髓纤维化伴巨脾造血干细胞移植中低强度预处理方案的一部分。
Tohoku J Exp Med. 2012 Dec;228(4):295-9. doi: 10.1620/tjem.228.295.
10
Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.脾内蓄积以及血管细胞黏附分子-1（VCAM-1）的缺失导致骨髓纤维化患者在异基因造血干细胞移植后出现植入缺陷。
Haematologica. 2016 Nov;101(11):1407-1416. doi: 10.3324/haematol.2016.146811. Epub 2016 Aug 4.
引用本文的文献
1
Molecular confirmation of alpha 1-antitrypsin deficiency in liver transplant setting: A province-wide experience.肝移植背景下α1-抗胰蛋白酶缺乏症的分子确诊：全省范围的经验
Hepatol Forum. 2023 Dec 7;5(2):68-72. doi: 10.14744/hf.2022.2022.0032. eCollection 2024.
本文引用的文献
1
Hematopoietic Cell and Solid Organ Transplantation in the Same Patient: Long-Term Experience at the University of Minnesota.同一患者的造血细胞移植与实体器官移植：明尼苏达大学的长期经验
Transplant Cell Ther. 2021 Jan;27(1):87.e1-87.e6. doi: 10.1016/j.bbmt.2020.09.005. Epub 2020 Sep 17.
2
Survival following allogeneic transplant in patients with myelofibrosis.异基因移植后骨髓纤维化患者的生存情况。
Blood Adv. 2020 May 12;4(9):1965-1973. doi: 10.1182/bloodadvances.2019001084.
3
Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects.肝移植中的免疫耐受机制-同种反应性 T 细胞与肝细胞的串扰及其治疗前景。
Front Immunol. 2019 Nov 19;10:2667. doi: 10.3389/fimmu.2019.02667. eCollection 2019.
4
Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.基于 NGS 的测序和基因融合panel 的临床实施用于疑似血液系统恶性肿瘤患者的筛查。
Eur J Haematol. 2019 Sep;103(3):178-189. doi: 10.1111/ejh.13272. Epub 2019 Jul 30.
5
State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019.最新综述：2019 年异基因造血干细胞移植治疗骨髓纤维化
Haematologica. 2019 Apr;104(4):659-668. doi: 10.3324/haematol.2018.206151. Epub 2019 Mar 14.
6
Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.原发性骨髓纤维化中的骨髓纤维化：致病机制及转化生长因子-β的作用
Stem Cell Investig. 2016 Feb 26;3:5. doi: 10.3978/j.issn.2306-9759.2016.02.03. eCollection 2016.
7
Hematopoietic Cell Transplantation after Solid Organ Transplantation.实体器官移植后的造血细胞移植
Biol Blood Marrow Transplant. 2015 Dec;21(12):2123-2128. doi: 10.1016/j.bbmt.2015.08.004. Epub 2015 Aug 10.
8
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT.实体器官移植受者的异基因造血干细胞移植：欧洲血液与骨髓移植组的一项回顾性多中心研究
Am J Transplant. 2015 Mar;15(3):705-14. doi: 10.1111/ajt.13017. Epub 2015 Feb 3.
9
Transplantation tolerance: from theory to clinic.移植耐受：从理论到临床
Immunol Rev. 2014 Mar;258(1):64-79. doi: 10.1111/imr.12154.
10
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.布加综合征和门静脉血栓形成中的骨髓增殖性肿瘤：一项荟萃分析。
Blood. 2012 Dec 13;120(25):4921-8. doi: 10.1182/blood-2011-09-376517. Epub 2012 Oct 4.
Zotero 插件